Gruppo Italiano Malattie Ematologiche Dell'adulto
Clinical trials sponsored by Gruppo Italiano Malattie Ematologiche Dell'adulto, explained in plain language.
-
New study investigates why some AML patients face early bleeding or clotting risks
Knowledge-focused Recruiting nowThis observational study examines a specific group of patients with a type of acute myeloid leukemia (AML) that has an NPM1 mutation. Researchers want to see if a particular subset, called APL-like, is linked to early blood vessel problems like bleeding or clots. The study will l…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Real-World data on SVd combo for myeloma: will it hold up outside trials?
Knowledge-focused Recruiting nowThis observational study is collecting information on how well the combination of selinexor, bortezomib, and dexamethasone (SVd) works for adults with multiple myeloma who have already tried 1 to 3 other treatments. Researchers will track 159 patients for about 3 years to see how…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:53 UTC